Ayala Pharmaceuticals Inc (ADXS)

[bomba_travel]

They certainly appear to be orchestrating an illiquid squeeze if good news soon re: data or FDA feedback.

However, the 75M post-split shares available to issue will loom large over anyone looking to enter. The co will be able to reduce the entire current capital structure to roughly 6% of the "new" company should all those shares be issued. No-debt companies financing in this way might as well be a BK to long term holders.

FWIW, still holding underwater. It's a setback but not a catastrophe if my investment continues its apparent path to $0.

Best to you